Smithers C Jason, Hamilton Thomas E, Manfredi Michael A, Rhein Lawrence, Ngo Peter, Gallagher Dorothy, Foker John E, Jennings Russell W
Esophageal Atresia Treatment Program, Department of Surgery, Boston Children's Hospital, Boston, MA 02115.
Esophageal Atresia Treatment Program, Department of Surgery, Boston Children's Hospital, Boston, MA 02115.
J Pediatr Surg. 2017 Mar;52(3):424-430. doi: 10.1016/j.jpedsurg.2016.08.012. Epub 2016 Aug 31.
Recurrent trachea-esophageal fistula (recTEF) is a frequent (5%-10%) complication of congenital TEF (conTEF) and esophageal atresia (EA) repair. In addition, postoperative acquired TEF (acqTEF) can occur in addition to or even in the absence of prior conTEF in the setting of esophageal anastomotic complications. Reliable repair often proves difficult by endoluminal or standard surgical techniques. We present the results of an approach that reliably identifies the TEF and facilitates airway closure as well as repair of associated tracheal and esophageal problems.
Retrospective review of 66 consecutive patients 2009-2016 (55 referrals and 11 local) who underwent repair via reoperative thoracotomy or cervicotomy for recTEF and acqTEF (IRB P00004344). Our surgical approach used complete separation of the airway and esophagus, which reliably revealed the TEF (without need for cannulation) and freed the tissues for primary closure of the trachea and frequently resection of the tracheal diverticulum. For associated esophageal strictures, stricturoplasty or resection was performed. Separation of the suture lines by rotational pexy of the both esophagus and the trachea, and/or tissue interposition were used to further inhibit re-recurrence. For associated severe tracheomalacia, posterior tracheopexy to the anterior spinal ligament was utilized.
The TEFs were recurrent (77%), acquired from esophageal leaks (26%), in addition to persistent or missed H-type (6%). Seven patients in this series had multiple TEFs of more than one category. Of the acqTEF cases, 6 were esophagobronchial, 10 esophagopulmonic, 2 esophagotracheal (initial pure EA cases), and 2 from a gastric conduit to the trachea. Upon referral, 18 patients had failed endoluminal treatments; and open operations for recTEF had failed in 18 patients. Significant pulmonary symptoms were present in all. During repairs, 58% were found to have a large tracheal diverticulum, and 51% had posterior tracheopexy for significant tracheomalacia. For larger esophageal defects, 32% were treated by stricturoplasty and 37% by segmental resection. Rotational pexy of the trachea and/or esophagus was utilized in 62% of cases to achieve optimal suture line separation. Review with a mean follow-up of 35months identified no recurrences, and resolution of pulmonary symptoms in all. Stricture treatment required postoperative dilations in 30, and esophageal replacement in 6 for long strictures. There was one death.
This retrospective review of 66 patients with postoperative recurrent and acquired TEF following esophageal atresia repair is the largest such series to date and provides a new categorization for postoperative TEF that helps clarify the diagnostic and therapeutic challenges for management.
复发性气管食管瘘(recTEF)是先天性气管食管瘘(conTEF)和食管闭锁(EA)修复术后常见(5%-10%)的并发症。此外,术后获得性气管食管瘘(acqTEF)可在食管吻合口并发症的情况下出现,甚至在既往无conTEF时也可发生。通过腔内或标准手术技术进行可靠的修复往往很困难。我们介绍一种方法的结果,该方法能可靠地识别气管食管瘘,并有助于气道闭合以及相关气管和食管问题的修复。
回顾性分析2009年至2016年连续66例患者(55例转诊患者和11例本地患者),这些患者因recTEF和acqTEF接受了再次开胸手术或颈部切开修复术(机构审查委员会P00004344)。我们的手术方法采用气道和食管完全分离,这能可靠地显露气管食管瘘(无需插管),并使组织游离以进行气管一期闭合,且常需切除气管憩室。对于相关的食管狭窄,进行狭窄成形术或切除术。通过食管和气管的旋转固定以及/或组织间置来分离缝线,以进一步防止复发。对于相关的严重气管软化,采用将气管后壁固定于前纵韧带的方法。
气管食管瘘为复发性(77%),由食管漏引起(26%),此外还有持续性或漏诊的H型(6%)。本系列中有7例患者有不止一种类型的多个气管食管瘘。在acqTEF病例中,6例为食管支气管瘘,10例为食管肺瘘,2例为食管气管瘘(最初为单纯EA病例),2例为胃造瘘管至气管瘘。转诊时,18例患者腔内治疗失败;18例recTEF患者开胸手术失败。所有患者均有明显的肺部症状。修复过程中,58%的患者发现有大的气管憩室,51%的患者因严重气管软化进行了气管后壁固定。对于较大的食管缺损,32%采用狭窄成形术治疗,37%采用节段切除术治疗。62%的病例采用气管和/或食管旋转固定以实现最佳的缝线分离。平均随访35个月的复查发现无复发,所有患者肺部症状均缓解。狭窄治疗中,30例患者术后需要扩张,6例因长段狭窄需要进行食管置换。有1例死亡。
这项对66例食管闭锁修复术后复发性和获得性气管食管瘘患者的回顾性研究是迄今为止最大的此类系列研究,为术后气管食管瘘提供了新的分类,有助于明确管理中的诊断和治疗挑战。